Education
About Us
Working with TipRanks
Follow Us
Neuroscientific Biopharmaceuticals Ltd. (AU:NSB)
ASX:NSB
RESEARCH TOOLSreports
Summary of all the Indicators
Overall Consensus
Strong Buy
16Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Neuroscientific Biopharmaceuticals Ltd. is a Buy.
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) 20-Day exponential moving average is 0.17, while Neuroscientific Biopharmaceuticals Ltd.’s (NSB) share price is AU$0.18, making it a Buy.
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) 50-Day exponential moving average is 0.16, while Neuroscientific Biopharmaceuticals Ltd.’s (NSB) share price is AU$0.18, making it a Buy.
Neuroscientific Biopharmaceuticals Ltd. (NSB) Pivot Points
Classic
0.16
0.16
0.17
0.17
0.17
0.17
0.18
Fibonacci
0.16
0.17
0.17
0.17
0.17
0.17
0.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Neuroscientific Biopharmaceuticals Ltd. (NSB) Moving Averages
MA5
0.17Buy
0.17Buy
MA10
0.17Buy
0.17Buy
MA20
0.17Buy
0.17Buy
MA50
0.18Buy
0.16Buy
MA100
0.12Buy
0.13Buy
MA200
0.08Buy
0.10Buy
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) 10-Day exponential moving average is 0.17, while Neuroscientific Biopharmaceuticals Ltd.’s (NSB) share price is AU$0.18, making it a Buy.
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) 100-Day exponential moving average is 0.13, while Neuroscientific Biopharmaceuticals Ltd.’s (NSB) share price is AU$0.18, making it a Buy.
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) stock price is AU$0.18 and Neuroscientific Biopharmaceuticals Ltd.’s (NSB) 50-day simple moving average is 0.18, creating a Buy signal.
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) stock price is AU$0.18 and Neuroscientific Biopharmaceuticals Ltd.’s (NSB) 100-day simple moving average is 0.12, creating a Buy signal.
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) stock price is AU$0.18 and Neuroscientific Biopharmaceuticals Ltd.’s (NSB) 200-day simple moving average is 0.08, creating a Buy signal.
Neuroscientific Biopharmaceuticals Ltd. (NSB) Technical Indicators
RSI (14)
52.28
Neutral
STOCH (9,6)
59.26
Neutral
STOCHRSI (14)
55.56
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
21.00
Neutral
Williams %R
-22.22
Buy
CCI (14)
35.47
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
45.07
Neutral
ROC
5.88
Buy
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) Relative Strength Index (RSI) is 52.28, creating a Neutral signal.
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) Trend Strength Indicator (ADX) is 21.00, creating a Neutral signal.
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) Commodity Channel Index (CCI) is 35.47, creating a Neutral signal.
Neuroscientific Biopharmaceuticals Ltd.’s (NSB) Price Rate of Change (ROC) is 5.88, creating a Buy signal.
FAQ
Is NSB a Buy, Hold, or Sell?
Based on NSB’s technical indicators, NSB is a Strong Buy.
What is NSB’s RSI (14)?
NSB’s RSI (14) is 52.28, which suggests NSB is a Neutral.
What is NSB’s MACD?
NSB’s MACD is >-0.01, which suggests NSB is a Buy.
What is NSB’s 5-day moving average?
NSB’s 5-day moving average is 0.17, which suggests NSB is a Buy.
What is NSB’s 20-day moving average?
NSB 20-day moving average is 0.17, which suggests NSB is a Buy.
What is NSB’s 50-day moving average?
NSB’s 50-day moving average is 0.18, which suggests NSB is a Buy.
What is NSB’s 200-day moving average?
NSB’s 200-day moving average is 0.08, which suggests NSB is a Buy.
What is NSB’s Williams % R (14)?
NSB’s Williams % R (14) is -22.22, which suggests NSB is a Buy.
What is NSB’s CCI (14)?
NSB’s CCI (14) is 35.47, which suggests NSB is a Neutral.
What is the share price of Neuroscientific Biopharmaceuticals Ltd.?